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1. Introduction 
Cancer is a major cause of death throughout the world, especially in the industrially 
developed nations. Minimally invasive and effective treatments are thus urgently required. 
Small interfering RNA (siRNA) is a possible candidate because it selectively decomposes 
and silences the target genes (Fire et al., 1998) associated with disease progression. 
However, the obstacle to the development of siRNA as a therapeutic agent results from the 
absence of an effective system for delivering siRNA to the target region (Li et al., 2006; Toub 
et al., 2006). 
In this context, we previously devised functional nanoparticles composed of iron oxide 
crystals as the siRNA-delivery system to magnetically augment the accumulation of siRNA 
at target regions (Namiki et al., 2009). Among the magnetic materials available for 
biomedical applications, including gene delivery, iron oxide forms, such as magnetite 
(Fe3O4) and maghemite (-Fe2O3), have been widely investigated (Xie et al., 2009; Lin et al., 
2008; Laurent et al., 2008; Gupta et al., 2005) because of their comparatively low cytotoxicity 
and dependable degree of magnetism. 
In the field of information technology, meanwhile, various kinds of magnetic storage 
devices, such as floppy disks, hard disks and magneto-optical disks have been developed. 
Among the ferromagnetic materials used in ultra-high density storage devices, iron nitride 
has several advantages, as follows (Sugita et al., 1994; Takahashi et al., 1999; Hattori et al., 
2001). (1) Iron nitride displays a greater degree of magnetization compared with iron oxide, 
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even when the nanocrystal-size is small. (2) Iron nitride is an iron-based material, and iron is 
cheap and abundant. (3) Iron nitride is a much cheaper ferromagnetic material than other 
ferromagnetic materials, such as FePt (Sun et al., 2000). (4) Iron nitride is made from non-
toxic and decomposable chemical elements such as iron and nitride. The spherical iron 
nitride nanocrystal is therefore an attractive material, not only as an ultra-high density data 
storage device, but also as a gene therapy vector in biomedical technology fields. 
The absorption force of magnetic nanoparticles to a magnet can be enhanced by the 
optimization of the magnetic materials. Furthermore, for biomedical applications, iron 
nitride is expected to be a good magnetic material candidate if it is able to display a similar 
low degree of cytotoxicity as iron oxide. However, iron nitride nanoparticles for biomedical 
applications have not been previously reported. We have devised an innovative 
Fe16N2/ cationic lipid nanocomposite and tested it in the magnetically guided silencing of 
target genes in cancer cells. Through an interdisciplinary fusion of the advances in various 
scientific fields, we were able to develop a novel gene delivery tool. This tool is comprised of 
magnetic nanoparticles composed of an iron nitride nanocrystal-core and a cationic lipid-
shell with high affinity genes. 
In this chapter, we describe the enhanced magnetism and gene silencing effect of a 
magnetic nanocomposite made from iron nitride instead of the conventionally used iron 
oxide, and we report the potential of the iron nitride/ cationic lipid nanocomposite as 
magnetically guided gene therapeutic vector which delivers siRNA into cells. Initially, we 
describe the preparation and purification procedures used for this nanocomposite. We 
prepared a magnetic fluid in which oleic acid-coated iron nitride nanocrystals were 
dispersed in chloroform. Through a further development of our previously devised 
procedure (Namiki et al., 2009), the oleic acid-coated iron nitride was assembled with the 
cationic lipid via hydrophobic interaction. Subsequently, we report the morphological and 
physiological properties of this composite, termed LipoFeN. In addition, siRNA designed 
to knockdown target genes and cationic lipid-coated iron nitride nanocrystals were mixed 
to form the complexes through electrostatic force. Finally, we show the degree of 
magnetic attraction, gene silencing effect and cytotoxic effect of this siRNA-loaded 
nanocomposite. 
2. Preparation and morphology of the iron nitride/metallic oxide core shell 
nanostructure 
Initially, magnetite nanocrystals with an approximate 20 nm diameter were synthesized as 
follows. FeCl3 (0.04 mol; Wako, Tokyo, Japan) and FeCl2 (0.02 mol; Wako) were dissolved in 
25 ml of distilled water. When 25 ml of ammonium hydroxide (25%) were vigorously mixed 
with this solution, magnetite slurry was precipitated. Subsequently, on the surface of the 
dried magnetite nanocrystals, yttrium and aluminum were deposited in the solution-
dispersed magnetite nanocrystals. These dried particles were deoxidized with hydrogen gas 
and then continuously treated with NH3 gas. Finally, the iron nitride/ metallic oxide core 
shell nanostructure was obtained (Sasaki et al., 2005). The shell layer, which is composed of 
yttrium-oxide and aluminum oxide, has the roles of preventing iron nitride oxidization and 
decomposition, and thus of maintaining the magnetism of the iron nitride. The 
nanostructure was examined using transmission electron microscopy (TEM), which 
revealed that this nanocomposite has an average diameter of 26 nm and approximate 3.5 nm 
shell thickness (Fig. 1). 
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Fig. 1. Schematic representation and transmission electron micrograph of the Fe16N2/ metal 
oxide core shell nanocomposite. 
3. Physiological properties of the iron nitride/metallic oxide core shell 
nanostructure 
The crystal structure of the particles was examined with an X-ray diffractometer (XRD). The 
surface condition was investigated using X-ray photoelectron spectroscopy (XPS). Magnetic 
measurements were carried out using a vibration sample magnetometer (VSM) by applying 
the maximum field of 1270 kA/ m (16 kOe). 
Data was acquired using a coupled Theta: 2-Theta scan on a Rigaku Ultima-III diffractomer 
equipped with a copper x-ray tube, parafocusing optics, computer-controlled variable slits, 
and a diffracted beam monochromator. Figure 2 shows the best matches after comparing the 
background-subtracted raw data with that of the ICDD/ ICSD diffraction database. As 
expected, the primary phase is Fe16N2. There is also a small amount of maghemite. Note that 
the primary maghemite peak, near 36 degrees on 2-Theta, is somewhat shifted relative to the 
reference pattern. This indicates that the Fe:O ratio may be somewhat different than 2:3. 
Note also that no metallic iron was detected. This phase is strongly overlapped with Fe16N2, 
so trace amounts of Fe in Fe16N2 might not be detected.  
XPS data is quantified using relative sensitivity factors and a model that assumes a 
homogeneous layer. The analysis volume is the product of the analysis area (spot size or 
aperture size) and the depth of information. Photoelectrons are generated within the X-ray 
penetration depth (typically some number of microns), but only the photoelectrons within 
the top three photoelectron escape depths are detected. Escape depths are on the order of 
15-35 Å, which leads to an analysis depth of ~50-100 Å. Typically, 95% of the signal 
originates from within this depth. 
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Fig. 2. X-ray diffraction peaks originating in the Fe16N2/ metal oxide core shell 
nanocomposite were clearly observed. 
Instrument PHI Quantum 2000 
X-ray source Monochromated Alka 1486.6eV 
Acceptance Angle ±23° 
Take-off angle 45º 
Analysis area 1400mm x 300mm 
Charge Correction C1s 284.8 eV 
Table 1. Analytical parameters of XPS. 
Table 2 provides the atomic concentrations of the elements detected. The values given are 
normalized to 100% using the elements detected. Detection limits are approximately 0.05 to 
1.0 atomic %. The major factors affecting the detection limit are the element itself, 
interference and background. Chemical state assignments for a given element were made by 
consulting the reference data from the literature. Chemical state assignments must be 
considered as tentative in cases where the available reference data is limited or in cases 
where similar binding energies are observed for a number of different chemical states. Non-
linear least squares (NLLS) curve fitting has been applied to selected high resolution spectra 
to assist in possible chemical state assignment. The results of the NLLS fits are shown on the 
individual spectra. It should be noted that the curve fit routines are mathematical devices, 
and for a given peak a number of mathematically valid results may exist. 
1. The particle surfaces are predominantly composed of aluminum, iron, oxygen and 
carbon, with low levels of yttrium and trace levels of fluoride, magnesium and chlorine 
(Table 2). 
2. Aluminum is found within the cap of the binding energies consistent with Al2O3 (Fig. 
3b). While various reports on YxAlyOx have comparable aluminum binding energies, 
the yttrium data below suggests that such a species is not present in these samples. 
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3. Yttrium is found at a binding energy (157.8eV, Fig. 3c) most consistent with that of 
Y(OH)3 (157.7eV). Its binding energy is higher than that for the Y2O3 reference 
(~156.3eV). The yttrium binding energy for an Y3Al5O12 reference run was found to be 
157.1eV. Thus, the yttrium in this sample is most likely present in the form Y(OH)3. 
4. Iron is found predominantly as iron oxide, likely Fe2O3, based in part on the XRD data. 
Additionally, low levels of Fe nitride are present (Fig. 3b, Table 2). It is noted that XRD 
found the opposite (high levels of iron nitride with trace levels of Fe2O3). This 
discrepancy is due to sampling depth differences (i.e. XRD samples the entire particle, 
whereas XPS samples only the top 60-80Å). 
5. Trace levels of fluorine and chlorine are found as inorganic fluorides and chlorides, 
respectively. These may be associated with iron, magnesium, yttrium or aluminum. The 
levels are insufficient to allow confirmation using the respective spectra. 
6. Carbon is found predominantly as a hydrocarbon (C-C, C-H), with lower levels of 
oxigen-containing species, potentially including CO3 (data not shown). The low carbon 
levels observed coupled with its chemistry indicates that much, possibly all, of the 
carbon is present as adventitious carbon, which had adsorbed onto sample surfaces 
from the atmosphere. 
7. Magnesium does not exhibit any significant shift in its binding energies in different 
chemical states. 
8. Oxygen is present as a complex mixture of metal oxides/ hydroxides and organic 
oxygen. 
9. Note that the presence of low levels of nitrogen cannot be confirmed in this system due 
to interference from a secondary yttrium signal (data not shown). However, based on 
the low levels of iron nitride present (from the iron data) and the low nitrogen/ iron 
ratio (based on XRD having determined the iron nitride to be Fe16N2), nitrogen would 
only be present within the XPS information depth at concentrations of 0.07%, i.e. below 
the XPS detection limit for this element. 
The particle surfaces are composed predominantly of Al2O3, with lower levels of Y(OH)3 on 
Fe2O3. Only low levels of iron nitride (Fe16N2 based on the XRD data) are observed, 
indicating that XPS does not reach deep into the particle core (Table 3). Additionally, trace 
levels of inorganic chlorides, fluorides and magnesium are present. 
 
 
Table 2. Atomic concentrations (in %)a 
a Normalized to 100% of the elements detected. XPS does not detect H or He. 
b The presence of N could not be confirmed due to the interference from a secondary Y 
signal. 
 
Table 3. Iron chemical state (in % of total Fea) 
a The values in this table are percentages of the total atomic concentrations of the 
corresponding element shown in Table 2. 
www.intechopen.com
 Nanocrystal 
 
354 
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(b) 
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(c) 
 
 
(d) 
Fig. 3. The X-ray photoelectron spectroscopy profiles indicated that the metalic oxide shell 
was composed of aluminum (Al)-, yttrium (Y)- and iron (Fe)- oxides. 
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In terms of magnetism, Fe16N2/ metalic oxide nanocomposite displayed saturation 
magnetization (103.1 emu/ g) and coercive force (3055 Oe), while Fe3O4 displayed 50.8 
emg/ g and 0 Oe (Fig. 4). 
 
 
Fig. 4. The magnetization curve of the Fe16N2/ metalic oxide nanocomposite and Fe3O4. 
Fe16N2/ metallic oxide, red; Fe3O4, blue. 
4. Preparation of iron nitride/metallic oxide/oleic acid-based magnetic fluid 
The air-dried iron nitride/ metallic oxide core shell nanostructure was well dispersed in 
ammonium hydroxide (25%). This mixture was then heated to 95 oC and 55 ml of 10% oleic 
acid (Wako)/ dodecan (Wako) were added. In this process, the FeN-nanocomposites were 
coated with hydrophilic ammonium oleate, and the ammonium oleate began to decompose 
at 78 oC, with the evaporation of ammonia gas thus changing the FeN-nanocomposites 
coated with hydrophobic oleic acid upon continuous heating. As a result, a distinct phase 
separation between the upper organic portion, in which the oleic acid-coated FeN-
nanocomposites were stably dispersed, and the lower aqueous portion appeared. Most of 
the aqueous phase was removed using a pipette and the heating of the residue was 
continued until the remaining water had been completely evaporated. The oleic acid-coated 
FeN-nanocomposites were flocculated by the addition of 100 ml of acetone, and a 
permanent magnet was used to collect this magnetic flocculate while the supernatant liquid 
was poured off. Moreover, this flocculate was then washed with 80 ml of acetone to 
eliminate excess oleic acid and centrifuged at 800 G. Acetone was completely removed from 
the resulting precipitation under reduced pressure (10 mmHg) at room temperature. 
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Twenty micrograms of these dried oleic acid-coated FeN-nanocomposites were dispersed in 
5 ml of chloroform, so a chloroform-based magnetic fluid was finally obtained (Fig. 5, 6). 
 
Fig. 5. Dispersion of the oleic acid-coated Fe16N2/ metalic oxide nanocomposite in 
chloroform. The magnetic fluid (right) was composed of the oleic acid (green)-coated iron 
nitride/ metallic oxide nanocomposite (dark gray/light gray) dispersed in chloroform (yellow). 
5. Preparation of the iron nitride/metallic oxide/oleic acid/cationic lipid 
nanocomposite 
One microgram of a lipid mixture (DC-6-14 (Sogo Pharmacochemical, Tokyo, Japan): DOPE 
(Wako) = 1: 0.4; molar ratio) was dissolved in 0.5 ml of chloroform. The lipid mixture, along 
with the chloroform-based magnetic fluid containing 0.2 mg of oleic acid-coated 
Fe16N2/ metalic oxide nanocomposite, was introduced into a pear-shaped flask. Chloroform  
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(1) (2) 
 
(3) (4) 
Fig. 6. Magnetic attraction of the chloroform-based magnetic fluid composed of the oleic 
acid-coated Fe16N2/ metalic oxide nanocomposite. 
was added to this flask until the total volume reached 1 ml and mixed well. After the 
addition of 1 ml of distilled water, the mixture was agitated on a vortex mixer for 1 min and 
sonicated by a cup-horn type sonicator (Sonifier 250D, Branson, CT) with a maximum 
output for 2 min at 37oC. The flask containing a gray homogeneous suspension was attached 
to a rotary evaporator and rotated at 2.5 G. The contents were evaporated at 50 mmHg 
under strong sonication at 37oC. In this process, chloroform was evaporated off to yield a gel 
and the gel immediately collapsed to give a clear gray-colored suspension. The remaining 
chloroform was removed from this suspension at 10 mmHg for 10 min (room temperature). 
This suspension was sonicated with a maximum output for 30 min at 37oC, and finally, iron 
nitride/ metallic oxide/ oleic acid/ cationic lipid nanocomposite were obtained through 
hydrophobic interactions (Fig. 7). 
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6. Purification of the iron nitride/metallic oxide/oleic acid/cationic lipid 
nanocomposite from free cationic liposome. 
The magnetally attractive stainless steel (SUS 430) granule (size 0.4 mm) was pressed and 
sintered, until finally the sintered magnetic metal filter was obtained (diameter x height: 9.0 
x 10 mm). This filter was inserted in the cylinder. Both poles of twin neodymium magnets, 
which were placed horizontally and oppositely arranged, were magnetically attracted on the 
column at the region of the stainless filter (Fig. 8). Under a magnetic field, magnetic 
nanoparticles were captured by the stainless steel filter of the syringe column, and magnetic 
crystal-free lipid vesicles lacking magnetic nanocrystals were eliminated. In the absence of a 
magnetic field, magnetitc nanoparticles were eluted from the filter (Fig. 9). 
 
 
 
(1) 
 
 
(2) 
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(3) 
 
 
(4) 
Fig. 7.  Schematic representation of the preparation of the cationic lipid-coated 
ferromagnetic nanocomposite. 
1) The magnetic fluid was composed of the oleic acid (green)-coated iron nitride/ metallic 
oxide nanocomposite (dark gray/light gray) dispersed in chloroform (yellow). The 
hydrophobic chloroform-based magnetic fluid and phospholipids (pink) dissolved in 
chloroform were mixed. When this mixture and distilled water (blue) were poured in a pear-
shaped flask, an upper layer of aqueous phase and a lower layer of organic phase containing 
oleic acid-coated magnetic nanocrystals appeared. 
2) After vigorous agitation and sonication, micro droplets were stabilized by a phospholipid 
layer, and “inverted micelles”  formed.   
3) Removal of chloroform by strong vacuuming leads to a transformation of these inverted 
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micelles into a viscous gel state. 
4) After the induction of gel-collapse through the continuous vacuum, the hydrophobic 
groups of amphiphilic phospholipids and oleic acid joined together to form the hydrophilic, 
cationic lipid-coated ferromagnetic nanocomposite. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8. Photograph of the stainless filter used for the purification of the cationic lipid-coated 
iron nitride/ metallic oxide nanocomposite. 
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Fig. 9. Schematic representation of the stainless filter used for the purification of the cationic 
lipid-coated iron nitride/ metallic oxide nanocomposite. 
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Fig. 10. Photograph and transmission electron micrograph (negative staining: Woodcock et 
al., 1991) of the cationic lipid-coated iron nitride/ metallic oxide, bar: 200 nm.  
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7. Magnetic attraction of the iron nitride/metallic oxide/oleic acid/cationic 
lipid nanocomposite 
The speed of magnetic attraction of the FeN-based nanocomposite and iron oxide based 
nanoparticles was compared (0 – 7.5 min). One hundred microliters of the aqueous solution 
containing 100 g of each nanoparticle was placed in each of the wells of a 96 well 
microplate and a magnetic field (200 mT) was irradiated under the well (Fig. 11). The 
magnetic attraction of these nanoparticles was recorded using a digital camera (Fig. 12). We 
confirmed that LipoFeN (iron nitride crystal-lipid nanostructures) were magnetically guided 
1.5 to 2 times more quickly than PolyMagTM (iron oxide crystal-polymer nanostructures: OZ 
Biosciences, Marseille, France) (Fig. 13). 
 
 
 
Fig. 11. The magnetic guidance of the magnetic nanoparticles using 96 well microplates. 
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Fig. 12. The speed of the magnetic attraction of the cationic lipid-coated iron nitride/ metallic 
oxide nanocomposite compared with iron oxide-based nanoparticles. 
8. The gene silencing in cells induced by the magnetically guided siRNA 
delivered by the iron nitride/metallic oxide/oleic acid/cationic lipid 
nanocomposite 
Under a magnetic field, the gene silencing effect of of LipoFeN, LipoMag (iron oxide 
crystal-lipid nanostructures) and  PolyMagTM  loaded with the luciferase-targeting siRNA 
were compared in a luciferase-expressing cancer cell line (Fig. 14). A human colon cancer 
cell line stably expressing luciferase (HT-29-luc2: Caliper, Alameda, CA) was cultured in 
McCoy's 5A (Invitrogen, Carlsbad, CA) complete medium containing 10% heat-
inactivated fetal bovine serum (Sigma). Cells were incubated at 37 oC in a humidified 
atmosphere of 5% CO2. 
Cells (1 x 104/ well) were cultured in 96 well plates for 12 hr. Either 25 l of siRNALuc (Table 
4) or 25 l of siRNANC was mixed with 25 l of each type of magnetic nanoparticles for 10 
min at room temperature. Cell culture medium was removed from the 96 well plate and 
cells were washed twice with PBS. Cells were incubated with the obtained 50 l of siRNA-
magnetic nanoparticle complex at 37 oC using a magnetic plate (Fig. 15). At 5 min after the 
initiation of the incubation, these complexes were removed, cells were washed twice with 
PBS and culture medium was dispensed to each well. Finally, luciferase activity was 
quantified at 48 hr after the incubation with these complexes. Luciferase activity was 
quantified as described previously (Takahashi et al., 1997). Briefly, cells were homogenized 
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Fig. 13. Schematic representation of the magnetic attraction of the iron nitride-based 
LipoFeN (blue) compared with the iron oxide-based PolyMag (brown). 
in cell lysis reagent (Toyo ink, Tokyo, Japan), and incubated for 15 min at room temperature. 
After centrifugation, 2.5 l of the supernatant were mixed with 100 l of luciferase assay 
reagent (Toyo ink), and the emission of light was measured with a luminometer (lumat 
LB9501; Berthold Designs, Berlin, Germany). For analysis of the total protein content, 10l 
of supernatant was assayed using the bicinchonic acid method, as described previously 
(Namiki et al., 1998). 
 
Sense sequence: 5’-CGUACGCGGAAUACUUCGAdTdT-3’ 
Antisense sequence: 5’- UCGAAGUAUUCCGCGUACGdTdT-3’ 
Target DNA sequence: AACGTACGCGGAATACTTCGA 
Table 4. The sequence of siRNA targeted to the luciferase gene and the target sequence of 
luciferase DNA (Elbashir et al., 2001). All Stars NC siRNA (siRNANC: Qiagen, Valencia, CA), 
which was used as the negative control nonsense siRNA, was designed to be a non-targeting 
sequence bearing no significant homology to the sequence of the human or murine 
transcripts. The negative control was used to eliminate non-specific off-target effects. These 
siRNAs were the most thoroughly tested and validated as a positive control or a negative 
control available from Qiagen. 
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Fig. 14. Schematic representation of the magnetic guidance of siRNA loaded with the 
magnetic nanoparticles and of the silencing of the luciferase gene. 
The gene silencing effect (the % knockdown of luciferase activity) of each type of magnetic 
nanoparticle was calculated (Fig. 16) using the following formula. 
[the % knockdown of luciferase activity]= 100 - 100 x [the activity of luciferase for samples 
transfected with siRNAluc] /  [the activity of luciferase for samples transfected with 
siRNANC].  
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Fig. 15. Schematic representation of the magnetic attraction of the magnetic nanoparticles to 
the cultured cells using a magnetic plate (200 mT). 
 
Fig. 16. The magnetically guided target gene silencing of the Fe16N2/ cationic lipid (red), iron 
oxide/ cationic lipid (light blue) and iron oxide-based PolyMagTM (blue) in cancer cells. Cells 
were incubated with LipoFeN/ siRNALuc, LipoFeN/ siRNANC, LipoMag/ siRNALuc, 
LipoMag/ siRNANC, (all of which included 90-720 ng of total lipids and 7.8-31.3 ng of 
siRNA), PolyMagTM/ siRNALuc or PolyMagTM/ siRNANC (both of which included 12.5-100 nl 
of PolyMagTM and 7.8-31.3 ng of siRNA). At 48 h after the incubation with the complexes for 
5 min, the degree of the knockdown of luciferase-expression was evaluated. LipoFeN 
containing 360 ng of total lipid and 15.6 ng of siRNALuc per 1 x 104 cells displayed a greater 
gene silencing effect than LipoMag (containing 360 ng of total lipid) and PolyMagTM under 
each optimized condition. The data given are the averages of two different experiments, 
each performed in triplicate (n= 6); bars, SD. 
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9. Cytotoxicity of the iron nitride/metallic oxide/oleic acid/cationic lipid 
nanocomposite 
We evaluated the cytotoxicity of magnetic nanoparticles by the LDH (lactate 
dehydrogenase) release assay. This assay is recommended instead of the MTT assay (Heeg 
et al., 1985) when the magnetic lipid nanoparticle-mediated cytotoxicity is measured 
(Soenen et al., 2007). In particular, the LDH release assay (Korzeniewski et al., 1983; Decker 
et al., 1988) is used for the quantitative analysis of cell death be measuring the LDH activity 
liberated from cells with cell membrane injuries, such the cell membrane lysed by drugs. 
This assay can be used for the determination of the toxicity of various agents, utilizing 
cultured cells. In the presence of NAD, LDH catalyzes the conversion of lactate to pyruvate. 
Lactate is oxidized to pyruvate and an equivalent amount of NAD is reduced to NADH. The 
NADH formed reduces nitrotetrazolium blue in the presence of diaphorase to produce blue 
colored Diformazan (Fig. 17), the absorbance wavelength of which is 560 nm. 
 
 
 
 
Fig. 17. Principle of the LDH release assay 
HT-29-luc2 cells  (1 x 104 cells/ well of a 96 well microplate) were incubated with each type 
of magnetic nanoparticles or with culture medium alone for 5 min under the magnetic field. 
After the removal of each medium, cells were washed twice with PBS and cultured with 
culture medium for 48 hr in a 5% CO2 incubator at 37 oC. After the removal of the culture 
medium, cells were washed twice with PBS and 75 l of 0.2% Tween 20/ PBS was added to 
the well. The plate was allowed to stand for 15 min at room temperature and moderately 
agitated. The plates were centrifuged for 3 min at 1000 rpm and 50 l of supernatant was 
collected. Five milliliters of color reagent containing nitrotetrazolium blue (3.7 mg), 
diaphorase and NADH, and 5 ml of buffer solution containing DL-lithium lactate (25 mg) 
were mixed to obtain the coloring solution. Fifty microliters of this coloring solution and 50 
l of supernatant were mixed. At 45 min after the mixture (room temperature), 100 l of 
hydrochloric acid (0.5 mol/ l) were added to each well. Finally, the absorbance of the 
reaction mixture was measured with a microplate reader at 560 nm after termination of the 
coloring reaction. The percentage of cell viability was calculated (Fig. 18) using the 
following formula. 
 
% cell viability = S/ N x 100 
(S: Absorbance of the sample; N: Absorbance of non-treated negative control cells) 
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Fig. 18. The cytotoxicity of the iron nitride-based nanocomposite compared with the iron 
oxide-based nanocomposite. To eliminate non-specific cytopathic effects, we confirmed that 
cell viability was over 85% of the non-treated cell at 48 h after gene silencing under the 
optimized conditions of siRNA-transfection using an LDH release assay procedure. Cells 
were incubated with LipoFeN/ siRNALuc (red), LipoMag/ siRNALuc (light blue) or 
PolyMagTM/ siRNALuc (blue) in a similar manner as Figure 16. The data given are the 
averages of two different experiments, each performed in triplicate (n= 6); bars, SD. 
10. Conclusion 
We were able to successfully enhance the gene silencing effect using a ferromagnetic iron 
nitride-based nanocomposite instead of an iron oxide-based nanocomposite. In summary, 
the newly devised ferromagnetic crystal–lipid nanostructures comprise a highly efficient, 
magnet-guided delivery system of siRNA. Using the Fe16N2/ cationic lipid nanocomposite 
achieved a better gene silencing effect than the major commercially available iron oxide-
based magnetic vector, PolyMagTM, even with a short incubation time, and the expression of 
the target gene was effectively inhibited. The formulations of iron nitride crystal–lipid 
nanostructures clearly have the potential for widespread use as high-performance gene 
delivery systems for cancer cell-targeted RNA interference. 
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